GHK-Cu (Copper Peptide)

1. Quick Facts

Category: Copper Peptide / Regenerative Peptide

Risk Level: Moderate

Research Status: Emerging Human Research

Administration: Subcutaneous Injection or Topical Application

Typical Frequency: Daily

Estimated Half-Life: Short Plasma Half-Life

Primary Research Interest: Skin Health / Tissue Repair / Hair Support

Important Disclaimer

This material is provided strictly for educational and informational purposes related to peptide research and regenerative compounds. GHK-Cu is a biologically active copper-binding peptide capable of influencing tissue repair signaling, collagen pathways, inflammation, and skin remodeling mechanisms. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.

2. Summary

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring human copper-binding tripeptide first identified in plasma and later found in saliva and urine. Unlike many experimental peptides discussed within peptide communities, GHK-Cu is an endogenous molecule whose concentration appears to decline with age.

Research interest in GHK-Cu commonly centers around tissue repair, wound healing, collagen production, skin rejuvenation, inflammation modulation, and hair-support applications. The peptide has been studied in both regenerative medicine and cosmetic science, making it one of the most extensively researched compounds in the CKF library.

What People Commonly Claim

Improves skin quality
Reduces wrinkles
Increases collagen production
Accelerates wound healing
Promotes hair growth
Reverses aging
Enhances tissue repair
Improves recovery from injury

What the Literature Actually Shows

GHK-Cu is a naturally occurring human peptide.
Published research supports roles in wound healing, tissue remodeling, collagen regulation, and inflammatory signaling.
Human cosmetic studies have reported improvements in skin appearance and skin quality.
Hair-growth research is promising but less extensive than skin-related research.
The strongest evidence exists for dermatology and tissue-repair applications.
Broader anti-aging and longevity claims remain under investigation.

CKF Transparency Note: GHK-Cu differs from many experimental peptides in that it is a naturally occurring human peptide with a relatively large body of published research. Evidence supporting roles in wound healing, tissue remodeling, collagen regulation, and skin health is stronger than for many compounds discussed within peptide communities. However, some anti-aging, hair-regrowth, and broad regenerative claims extend beyond the currently available human evidence. Readers should distinguish between well-supported dermatological applications and broader longevity claims that remain under investigation.

3. Reconstitution Guide

Vial Size: 50 mg
Dilutant Type: BAC Water
Amount of Dilutant Added: 5 mL
Final Concentration: 10.00 mg/mL

At this concentration:
• 1.0 mg = 0.100 mL (10 units)
• 2.0 mg = 0.200 mL (20 units)

*Different vial sizes may limit reconstitution volume. If your product differs from the specifications listed here, please use the Peptide Calculator to calculate custom concentrations and dosing protocols.

4. Route of Administration

GHK-Cu is most commonly administered as either a subcutaneous injectable peptide or a topical skin application compound.

Primary Route: SubQ Injection or Topical Application
Preferred Timing: Flexible daily administration timing
Administration Notes: Frequently researched for skin quality, tissue repair, cosmetic applications, and regenerative signaling.

5. Typical Research Protocols

Product Strength: 10.00 mg/mL
Typical Delivered Amount: 1.0–2.0 mg daily
Frequency: Daily
Cycle Length: 8–12 weeks on / 2–4 weeks off
Special Notes: Topical GHK-Cu formulations are common in cosmetic science and are frequently used for skin-quality and hair-support applications. Localized injectable use near injured tissues is often discussed, although robust evidence supporting site-specific targeting remains limited.

6. Mechanism of Action

GHK-Cu appears to influence multiple regenerative pathways involving collagen synthesis, extracellular matrix remodeling, inflammatory regulation, angiogenesis, antioxidant signaling, and tissue repair.

Collagen production signaling
Tissue remodeling support
Wound-healing enhancement
Anti-inflammatory signaling
Antioxidant activity
Hair follicle support pathways
Gene-expression modulation

Research suggests that GHK-Cu may regulate thousands of genes involved in tissue repair, inflammation control, and regenerative processes, helping explain its unusually broad range of observed biological effects.

7. Potential Benefits

Potential skin-quality improvements
Enhanced collagen signaling
Possible wound-healing support
Potential hair-support benefits
Improved tissue recovery signaling
Possible anti-inflammatory effects
Support for skin elasticity and firmness

8. Potential Risks / Side Effects

Moderate

Skin irritation
Injection-site irritation
Allergic reactions
Unknown long-term copper-signaling effects
Potential topical sensitivity reactions
Limited long-term injectable safety data

9. Half-Life

GHK-Cu is generally considered to have a relatively short circulating plasma half-life.

However, downstream effects involving collagen synthesis, tissue remodeling, inflammatory regulation, and gene-expression changes may persist substantially longer than measurable plasma concentrations.

10. Storage Information

Store refrigerated before and after reconstitution
Protect from direct light exposure
Avoid repeated freeze-thaw cycles
Maintain sterile handling practices during preparation

11. Contraindications / Warnings

Known copper metabolism disorders
Pregnancy or breastfeeding
Severe dermatological sensitivity
Known hypersensitivity to peptide compounds

12. Further Study

GHK-Cu possesses one of the strongest evidence bases among regenerative peptides currently discussed within peptide communities. Readers interested in the compound should focus on the distinction between well-supported dermatological applications and broader longevity claims that remain under investigation.

Current Evidence Gaps

Large-scale randomized human trials
Long-term injectable safety data
Direct comparison with established dermatology therapies
Direct comparison with established hair-loss treatments
Optimal dosing and administration routes
Longevity outcomes in humans

13. Research References

PubMed
PubMed Central (PMC)
NIH Publications
Regenerative medicine literature
Peer-reviewed dermatology journals
Cosmetic science literature

14. Last Reviewed

June 2026